Ultimo aggiornamento :
27/11/2024
Infostab
Elenco delle molecole
Elenchi sommari
Cerca compatibilità
Tabella di compatibilità del sito Y
Bibliografia
Le squadre di ricerca
valistab
poster
Connessioni
sponsor
Autori
Manuale d’uso
Bollettino
Salbutamol sulfate
Struttura chimica
Bibliografia : Salbutamol sulfate
tipo
pubblicazione
549
Rivista
Owsley HD, Rusho WJ.
Compatibility of common respiratory therapy drug combinations.
Int J Pharm Compound 1997 ; 1: 121-122.
665
Rivista
Blondino, FE, Baker M.
Stability of Nebulizer Admixtures.
Int J Pharm Compound 2005 ; 9, 4: 323-326.
2670
Rivista
Hunter DA, Yoo SD, Fox JL.
Stability of albuterol in continuous nebulization.
Int J Pharm Compound 1998 ; 2: 394-396.
2685
Rivista
Jacobson GA, Peterson GM.
Stability of ipratropium bromide and salbutamol nebuliser admixtures.
Int J Pharm Pract 1995 ; 3: 169-173.
2770
Rivista
Krämer I, Schwabe A, Lichtinghagen R, Kamin W.
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Pharmazie 2007 ; 62, 10: 760-766.
2774
Rivista
McKenzie J.E, Mario Cruz-Rivera M.
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
Ann Pharmacotherapy 2004 ; 38: 967-972.
2790
Rivista
Kamin W, Schwabe A, Krämer I.
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Int J COPD 2007 ; 1, 4: 599-607.
2960
Rivista
Gooch MD.
Stability of albuterol and tobramycin when mixed for aerosol administration.
Respiratory Care 1991 ; 36: 1387-1390.
3472
Rivista
Krämer I, Schwabe A, Kamin W.
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krankenhauspharmazie 2007 ; 28, 5: 170-178.
4280
Rivista
Gulley, S.L, Baltzley, S.M, Junkins, A.D, Murray, T.D, Simms, S.F, Sullivan, J.E, Al-Ghananeem A.M, O?Hagan A.R.
Sterility and Stability Testing of Preservative-free Albuterol.
J Pediatr Pharmacol Ther 2019 ; 24, 1: 53-57.
Mentions Légales